Post written by Árpád V. Patai, MD, from Semmelweis University, 2nd Department of Medicine, Budapest, Hungary. Although post-ERCP pancreatitis (PEP) is the most frequent complication of ERCP and mortality of severe PEP is high, ERCP is still inevitable in our therapeutic armamentarium, so it is fundamental to assess the efficacy of all potential preventive measures, …

Continue reading Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis